rs3213495
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004481.5(GALNT2):c.*834G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.15 in 297,766 control chromosomes in the GnomAD database, including 4,314 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.16 ( 2350 hom., cov: 33)
Exomes 𝑓: 0.14 ( 1964 hom. )
Consequence
GALNT2
NM_004481.5 3_prime_UTR
NM_004481.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.36
Publications
10 publications found
Genes affected
GALNT2 (HGNC:4124): (polypeptide N-acetylgalactosaminyltransferase 2) This gene encodes a member of the glycosyltransferase 2 protein family. Members of this family initiate mucin-type O-glycoslation of peptides in the Golgi apparatus. The encoded protein may be involved in O-linked glycosylation of the immunoglobulin A1 hinge region. This gene may influence triglyceride levels, and may be involved Type 2 diabetes, as well as several types of cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
GALNT2 Gene-Disease associations (from GenCC):
- congenital disorder of glycosylation, type iitInheritance: AR Classification: STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.416 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GALNT2 | NM_004481.5 | c.*834G>A | 3_prime_UTR_variant | Exon 16 of 16 | ENST00000366672.5 | NP_004472.1 | ||
| GALNT2 | NM_001291866.2 | c.*834G>A | 3_prime_UTR_variant | Exon 16 of 16 | NP_001278795.1 | |||
| GALNT2 | XM_017000964.3 | c.*834G>A | 3_prime_UTR_variant | Exon 17 of 17 | XP_016856453.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GALNT2 | ENST00000366672.5 | c.*834G>A | 3_prime_UTR_variant | Exon 16 of 16 | 1 | NM_004481.5 | ENSP00000355632.4 | |||
| GALNT2 | ENST00000485438.1 | n.2202G>A | non_coding_transcript_exon_variant | Exon 6 of 6 | 5 | |||||
| ENSG00000224407 | ENST00000414640.1 | n.*20C>T | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.161 AC: 24475AN: 152082Hom.: 2340 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
24475
AN:
152082
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.138 AC: 20024AN: 145566Hom.: 1964 Cov.: 0 AF XY: 0.136 AC XY: 10602AN XY: 77858 show subpopulations
GnomAD4 exome
AF:
AC:
20024
AN:
145566
Hom.:
Cov.:
0
AF XY:
AC XY:
10602
AN XY:
77858
show subpopulations
African (AFR)
AF:
AC:
972
AN:
4798
American (AMR)
AF:
AC:
1752
AN:
9668
Ashkenazi Jewish (ASJ)
AF:
AC:
244
AN:
3256
East Asian (EAS)
AF:
AC:
3435
AN:
7644
South Asian (SAS)
AF:
AC:
2722
AN:
25362
European-Finnish (FIN)
AF:
AC:
643
AN:
5422
Middle Eastern (MID)
AF:
AC:
41
AN:
518
European-Non Finnish (NFE)
AF:
AC:
9258
AN:
81620
Other (OTH)
AF:
AC:
957
AN:
7278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
753
1505
2258
3010
3763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.161 AC: 24521AN: 152200Hom.: 2350 Cov.: 33 AF XY: 0.162 AC XY: 12088AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
24521
AN:
152200
Hom.:
Cov.:
33
AF XY:
AC XY:
12088
AN XY:
74406
show subpopulations
African (AFR)
AF:
AC:
8839
AN:
41538
American (AMR)
AF:
AC:
2822
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
252
AN:
3468
East Asian (EAS)
AF:
AC:
2221
AN:
5158
South Asian (SAS)
AF:
AC:
598
AN:
4818
European-Finnish (FIN)
AF:
AC:
1394
AN:
10600
Middle Eastern (MID)
AF:
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8006
AN:
67998
Other (OTH)
AF:
AC:
329
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1007
2014
3020
4027
5034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
266
532
798
1064
1330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
849
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.